A systematic review and meta-analysis of soft tissue reconstruction following debridement of tibial osteomyelitis: Comparing muscle and fasciocutaneous flaps

胫骨骨髓炎清创术后软组织重建的系统评价和荟萃分析:肌肉瓣与筋膜皮瓣的比较

阅读:1

Abstract

INTRODUCTION: Tibial osteomyelitis is a serious condition, often resulting from trauma or orthopedic surgery, frequently requiring soft tissue reconstruction after debridement. This systemic review and meta-analysis compared outcomes of muscle versus fasciocutaneous flap reconstruction following debridement of tibial osteomyelitis. METHODS: Following PRISMA guidelines, MEDLINE, EMBASE, PubMed Central, and Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched. Prospective or retrospective comparative studies evaluating muscle and fasciocutaneous flap reconstruction following tibial osteomyelitis debridement were included. Non-comparative studies with only one flap type were excluded to reduce bias. Primary outcomes included osteomyelitis recurrence and flap failure; secondary outcomes assessed amputation rates and patient satisfaction. RESULTS: Six studies encompassing 207 patients (219 flaps) were included. The meta-analysis showed a trend towards lower osteomyelitis recurrence rate in the fasciocutaneous flaps, although this was not statistically significant in one scenario (odds ratio [OR] 3.35, 95 % CI 1.14-9.90 and OR 2.69 95 % CI 0.93-7.74). Significant flap loss rates were comparable, with no statistically significant difference (OR 1.68 95 % CI 0.45-6.25 and OR 1.12 95 % CI 0.30-4.23). Amputation rates were similar between flap types (OR 3.06 95 % CI 0.46-20.38). One study reported higher satisfaction with fasciocutaneous flaps regarding appearance (p = 0.048). CONCLUSION: Both flap types effectively support reconstruction in tibial osteomyelitis, providing well-vascularized tissue to help reduce recurrence. Our study focused on the tibia, a bone particularly vulnerable to trauma and devascularization, and identified that muscle and fasciocutaneous flap coverage provided similar clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。